Monte Rosa Therapeutics, Inc. (GLUE) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $448.66M | +2.3% |
| 2024 | $438.73M | +44.4% |
| 2023 | $303.75M | -11.3% |
| 2022 | $342.39M | -6.5% |
| 2021 | $366.33M | +641.9% |
| 2020 | $49.38M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $448.66M | +2.3% |
| 2024 | $438.73M | +44.4% |
| 2023 | $303.75M | -11.3% |
| 2022 | $342.39M | -6.5% |
| 2021 | $366.33M | +641.9% |
| 2020 | $49.38M | — |